secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenon Pharmaceuticals Inc. (XENE)
CIK:        0001582313
Form:       8-K
Filed at:   2025-07-03T23:59:59+00:00
Accession:  0000950170-25-093996
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Xenon CFO Sherry Aulin resigns; CEO Ian Mortimer appointed interim CFO
----------------------------------------------------------------------

- Sherry Aulin resigned as CFO, effective June 30, 2025.
- Ian Mortimer (President & CEO) appointed interim CFO effective June 30, 2025, serving as principal financial and accounting officer.
- No change to Mortimer's compensation in connection with the appointment.
- Mortimer's background previously disclosed in the April 24, 2025 proxy statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582313/000095017025093996/0000950170-25-093996-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582313/000095017025093996/xene-20250630.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-093996

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer